Sharma Ramavtar, Goyal Arun, Singh Renu, Khanduri Shruti, Ota Sarada, Goel Sumeet, Rana Rakesh Kumar, Singhal Richa, Shahi Vinod Kumar, Srikanth Narayanam, Swasticharan Leimapokpam, Dhiman Kartar Singh
Central Council for Research in Ayurvedic Sciences, New Delhi, 110058, India.
Central Council for Research in Ayurvedic Sciences, New Delhi, 110058, India.
J Ayurveda Integr Med. 2021 Jul-Sep;12(3):521-528. doi: 10.1016/j.jaim.2021.04.012. Epub 2021 Aug 4.
A study titled 'Integration of AYUSH (Ayurveda) with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)' implemented in India in three districts of three states, namely Bhilwara (Rajasthan), Gaya (Bihar), and Surendranagar (Gujarat) since 2015 for the management of various non-communicable diseases (NCDs) through integrated approach.
OBJECTIVE(S): To evaluate the effect of Ayurveda medication, lifestyle modification, and Yoga in integration with standard care for the management of essential hypertension.
A retrospective analysis of the demographic and clinical records available from NPCDCS-AYUSH Integration Project was done. The data of participants with Essential Hypertension (EHTN), aged between 30 and 60 years, who had completed six months integrated management as per the treatment protocol of the NPCDCS-AYUSH Integration project between July 2018 and March 2019 were taken and distributed in two groups based on their intervention. Those advised for lifestyle modification and Yoga in addition to standard care with any of the five medicines/combinations i.e. Amlodipine or Atenolol or Amlodipine + Atenolol or Losartan or Telmisartan were assigned Group I and those who were given Ayurveda medication, lifestyle modification and Yoga in addition to standard care were assigned to Group II. The change in blood pressure was analysed and dose reduction/discontinuation of conventional medications was also observed.
Data of 1938 participants who had completed treatment under the NPCDCS program was analysed. At the 6th month, systolic and diastolic blood pressure was significantly reduced (P < 0.01) in all categories of Group I and Group II from baseline. Further, the dose of conventional medicine was reduced in 33.1% of participants of Group I and in 30.4% participants of Group II when compared to 0 day while conventional medicines were discontinued in 15.1% of Group I and 36.7% of Group II participants.
Ayurveda medication along with lifestyle management and Yoga effectively controls systolic and diastolic blood pressure and further helps in reducing/discontinuation of dose of conventional medicines in EHTN participants.
一项名为“阿育吠陀(印度草医学)与国家癌症、糖尿病、心血管疾病及中风预防控制计划(NPCDCS)的整合”的研究自2015年起在印度三个邦的三个地区实施,即比勒瓦尔(拉贾斯坦邦)、加亚(比哈尔邦)和苏伦德拉纳加尔(古吉拉特邦),通过综合方法管理各种非传染性疾病(NCDs)。
评估阿育吠陀药物、生活方式改变和瑜伽与标准护理相结合对原发性高血压管理的效果。
对NPCDCS - 阿育吠陀整合项目中可用的人口统计学和临床记录进行回顾性分析。选取2018年7月至2019年3月期间,年龄在30至60岁之间、按照NPCDCS - 阿育吠陀整合项目治疗方案完成六个月综合管理的原发性高血压(EHTN)参与者的数据,并根据其干预措施分为两组。除标准护理外,被建议进行生活方式改变和瑜伽,并使用五种药物/组合中的任何一种,即氨氯地平或阿替洛尔或氨氯地平 + 阿替洛尔或氯沙坦或替米沙坦的参与者被分配到第一组;除标准护理外,接受阿育吠陀药物、生活方式改变和瑜伽的参与者被分配到第二组。分析血压变化,并观察传统药物的剂量减少/停用情况。
分析了1938名在NPCDCS项目下完成治疗的参与者的数据。在第6个月时,第一组和第二组所有类别的收缩压和舒张压与基线相比均显著降低(P < 0.01)。此外,与第0天相比,第一组33.1%的参与者和第二组30.4%的参与者传统药物剂量减少,第一组15.1%的参与者和第二组36.7%的参与者停用了传统药物。
阿育吠陀药物与生活方式管理和瑜伽相结合可有效控制收缩压和舒张压,并进一步有助于减少/停用EHTN参与者的传统药物剂量。